Â鶹ÊÓƵ

TORONTO — North American stock markets recovered from early losses on signs of a potential extension to the U.S. debt ceiling deadline. The day started weak with futures down about two per cent following declines on European markets.

CALGARY — Dow Inc. says it has plans to expand and decarbonize its petrochemicals site at Fort Saskatchewan, Alta. The U.S.-based chemical company says it will build a net-zero carbon emissions ethylene and derivatives complex at the site.

HALIFAX — Canada is facing a potential wave of terminations tied to mandatory workplace vaccine policies as a growing number of employers require workers to be fully inoculated against COVID-19 — or risk losing their jobs, legal experts say.

Transportation industry associations say the federal government's development of a national vaccine passport will be vital for airlines to carry out a vaccine mandate for air travellers.

NEW YORK (AP) — Melinda French Gates, already one of the world's most prominent philanthropists, will now take on the job of publisher. Gates has formed a nonfiction imprint with Flatiron Books, a division of Macmillan.

LONDON (AP) — The World Health Organization on Wednesday endorsed the world's first malaria vaccine and said it should be given to children across Africa in the hope that it will spur stalled efforts to curb the spread of the parasitic disease.

TORONTO — Cineworld Group PLC's chief executive was planning to sell off Cineplex Inc.'s RecRoom and signage business in a secret initiative he called "Project Jumanji." The U.K.

OTTAWA — The Conference Board of Canada cut its forecast for economic growth this year after the contraction seen in the second quarter. The think tank said Wednesday it expects real gross domestic product in Canada to grow 5.

The upcoming world premiere at the Dallas Symphony Orchestra of a classical music piece inspired by the late Supreme Court Justice Ruth Bader Ginsburg would probably have been impossible if not for a bunch of lawyers in the Chicago area, a Long Islan

MISSISSAUGA, Ont. — Baylis Medical Co. Inc. says it has signed a deal to sell its cardiology business to Boston Scientific Corp. for US$1.75 billion. The company is a developer of medical devices used in cardiology.